Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |